AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IOPAMIDOL
25 registrations across 7 African markets— 14 active
Markets with IOPAMIDOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SCANLUX INJECTABLE; IV (INFUSION) | 🇿🇼Zimbabwe | MDI HEALTHCARE | active | Dec 2027 |
| SCANLUX INJECTABLE; IV (INFUSION) | 🇿🇼Zimbabwe | MDI HEALTHCARE | active | Dec 2027 |
| SCANOPAM 300 INJECTION | 🇬🇭Ghana | — | active | Jun 2027 |
| SCANOPAM 300 INJECTION | 🇬🇭Ghana | — | active | Jun 2027 |
| SCANOPAM 370 INJECTION | 🇬🇭Ghana | — | active | Jun 2027 |
| SCANOPAM 370 INJECTION | 🇬🇭Ghana | — | active | Jun 2027 |
| PAMISCAN Solution injectable / 300 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 370 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 300 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 300 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 200 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 370 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| PAMISCAN Solution injectable / 200 mg/ml | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Aug 2014 |
| SCANLUX 300 Solution injectable / 300 mg/ml | 🇹🇳Tunisia | SANOCHEMIA Pharmazeutika | expired | Jun 2002 |
| SCANLUX 370 Solution injectable / 370 mg/ml | 🇹🇳Tunisia | SANOCHEMIA Pharmazeutika | expired | Jun 2002 |
| SCANLUX 370 Solution injectable / 370 mg/ml | 🇹🇳Tunisia | SANOCHEMIA Pharmazeutika | expired | Jun 2002 |
| SCANLUX 300 Solution injectable / 300 mg/ml | 🇹🇳Tunisia | SANOCHEMIA Pharmazeutika | expired | May 2002 |
| JOPAMIRON 370 50 ml | 🇿🇦South Africa | Axim Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| IOPAMIDOL PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | UNIQUE PHARMACEUTICA L LABORATORIES | active | — |
| IOPAMIDO-M solution injectable / 370 mg | 🇸🇳Senegal | MULTI-G BVBA LEEMSTRAAT 166 2018 ANTWERPEN, BELGIQUE | active | — |
| PAMISCAN solution injectable / 370mg / ml | 🇸🇳Senegal | MEDIS SENEGAL | active | — |
| IOPAMIDO-M solution injectable / 300 mg | 🇸🇳Senegal | MULTI-G BVBA LEEMSTRAAT 166 2018 ANTWERPEN, BELGIQUE | active | — |
| IOPAMIDOL PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | UNIQUE PHARMACEUTICA L LABORATORIES | active | — |
| PAMISCAN solution injectable / 300 mg / ml | 🇸🇳Senegal | MEDIS | active | — |
| Pamidol 370 Solution for injection | 🇹🇿Tanzania | UNIQUE PHARMACEUTICAL LABORATORIES (A Div. of J. B. Chemicals & Pharmaceuticals Ltd) | active | — |
IOPAMIDOL in Africa — Regulatory Overview
IOPAMIDOL is registered across 7 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, Ghana, Zimbabwe and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 14 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.